San Diego BioAtla Secures Up To $22.5M Financing
Tap title to read story
SAN DIEGO — BioAtla announced on Nov. 21 that it entered agreements providing flexible financing to support operations while it finalizes a strategic partnership. The company reported a $7.5 million advance from affiliates of Yorkville Advisors and funds managed by Anson Advisors, plus a Yorkville standby equity purchase commitment of up to $15 million to buy common stock at a 3% discount over three years. BioAtla said funding will maintain operational momentum as it aims to complete the strategic transaction by year-end. Announcements were distributed via GlobeNewswire and republished by multiple news outlets. Based on 5 articles reviewed and supporting research.
SAN DIEGO — BioAtla announced on Nov. 21 that it entered agreements providing flexible financing to support operations while it finalizes a strategic partnership. The company reported a $7.5 million advance from affiliates of Yorkville Advisors and funds managed by Anson Advisors, plus a Yorkville standby equity purchase commitment of up to $15 million to buy common stock at a 3% discount over three years. BioAtla said funding will maintain operational momentum as it aims to complete the strategic transaction by year-end. Announcements were distributed via GlobeNewswire and republished by multiple news outlets. Based on 5 articles reviewed and supporting research.
More context
Timeline
- 1. BioAtla operates as a clinical-stage company developing CAB antibody therapeutics prior to 2025.
- 2. 21st November 2025 — BioAtla issued a GlobeNewswire press release announcing financing agreements.
- 3. 21st November 2025 — Company entered Pre-paid Advance Agreements providing an aggregate $7.5 million advance.
- 4. 21st November 2025 — Company entered a Standby Equity Purchase Agreement with Yorkville for up to $15 million at a 3% discount over three years.
- 5. 21st November 2025 — BioAtla stated it remains on track to complete a strategic transaction by year-end to maintain operational momentum.
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
